Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02675829
Title Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

urinary bladder cancer

lung cancer

urinary system cancer

Advanced Solid Tumor

Therapies

Ado-trastuzumab emtansine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.